Italy adopts Commission line on CE marking
This article was originally published in Clinica
Executive Summary
The Italian regulatory authority has advised the health service that it may purchase and use non-CE-marked medical devices, which were in the distribution chain before June 14, when the Medical Devices Directive became mandatory. The Italians have followed the recommendation made by the European Commission earlier in June, which said that such devices could be sold provided they were already in the distribution chain.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.